XPERT MTB/RIF ASSAY

System, Nucleic Acid-based, Mycobacterium Tuberculosis Complex, Resistance Marker, Direct Specimen

CEPHEID

The following data is part of a De Novo classification by Cepheid with the FDA for Xpert Mtb/rif Assay.

Pre-market Notification Details

DeNovo IDDEN130032
Device Name:XPERT MTB/RIF ASSAY
ClassificationSystem, Nucleic Acid-based, Mycobacterium Tuberculosis Complex, Resistance Marker, Direct Specimen
Applicant CEPHEID 904 Caribbean Drive Sunnyvale,  CA  94089
ContactKerry J Flom
Product CodePEU  
CFR Regulation Number866.3373 [🔎]
DecisionGranted (DENG)
510(k) Premarket NotificationK131706
Review Advisory BoardMicrobiology
Classification AdvisoryMicrobiology
TypeDirect
Date Received2013-06-11
Decision Date2013-07-25
FDA ReviewDecision Summary
Reclassification Order:Reclassification Order

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
07332940000912 DEN130032 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.